For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251120:nRST2554Ia&default-theme=true
RNS Number : 2554I CVS Group plc 20 November 2025
20 November 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 19 November 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 19/11/2025
Aggregate number of Ordinary Shares purchased: 26,394
Lowest price paid per share (GBp): 1,128.00
Highest price paid per share (GBp): 1,146.00
Volume weighted average price paid per share (GBp): 1,136.55
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 71,237,440 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 71,237,440 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 503,343 Ordinary Shares in aggregate at a weighted average price
of 1,228.15 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
474 1130 19/11/2025 08:03:56 1336001733593938 XLON
232 1130 19/11/2025 08:03:56 1336001733593940 XLON
510 1132 19/11/2025 08:08:43 1336001733594775 XLON
140 1132 19/11/2025 08:08:43 1336001733594776 XLON
352 1130 19/11/2025 08:13:00 1336001733595304 XLON
271 1130 19/11/2025 08:13:00 1336001733595305 XLON
34 1140 19/11/2025 08:34:57 1336001733597594 XLON
110 1140 19/11/2025 08:34:57 1336001733597595 XLON
376 1140 19/11/2025 08:34:57 1336001733597596 XLON
200 1142 19/11/2025 08:36:14 1336001733597733 XLON
140 1144 19/11/2025 08:41:13 1336001733598261 XLON
289 1142 19/11/2025 08:42:33 1336001733598329 XLON
743 1144 19/11/2025 08:45:44 1336001733598640 XLON
822 1146 19/11/2025 08:47:01 1336001733598733 XLON
717 1142 19/11/2025 08:58:28 1336001733599793 XLON
213 1142 19/11/2025 08:58:29 1336001733599795 XLON
200 1142 19/11/2025 08:59:41 1336001733599926 XLON
281 1140 19/11/2025 09:02:00 1336001733600132 XLON
326 1140 19/11/2025 09:02:00 1336001733600133 XLON
171 1140 19/11/2025 09:02:00 1336001733600134 XLON
341 1136 19/11/2025 09:06:28 1336001733600569 XLON
234 1134 19/11/2025 09:22:13 1336001733602112 XLON
78 1134 19/11/2025 09:24:41 1336001733602252 XLON
659 1132 19/11/2025 09:34:33 1336001733602880 XLON
734 1132 19/11/2025 09:34:33 1336001733602882 XLON
715 1128 19/11/2025 09:55:56 1336001733604445 XLON
138 1128 19/11/2025 09:55:56 1336001733604446 XLON
77 1128 19/11/2025 10:03:04 1336001733605086 XLON
562 1128 19/11/2025 10:03:04 1336001733605087 XLON
1103 1132 19/11/2025 10:12:11 1336001733606060 XLON
1103 1132 19/11/2025 10:23:58 1336001733606906 XLON
353 1132 19/11/2025 10:23:58 1336001733606910 XLON
596 1132 19/11/2025 10:23:58 1336001733606911 XLON
120 1132 19/11/2025 10:23:58 1336001733606912 XLON
177 1130 19/11/2025 10:41:24 1336001733608337 XLON
114 1130 19/11/2025 10:41:24 1336001733608339 XLON
5 1132 19/11/2025 10:52:02 1336001733610178 XLON
1112 1138 19/11/2025 10:55:24 1336001733610413 XLON
545 1138 19/11/2025 10:56:05 1336001733610510 XLON
128 1138 19/11/2025 10:56:07 1336001733610514 XLON
225 1142 19/11/2025 11:11:47 1336001733611798 XLON
355 1142 19/11/2025 11:11:47 1336001733611799 XLON
103 1140 19/11/2025 11:17:48 1336001733612356 XLON
6 1140 19/11/2025 11:17:48 1336001733612357 XLON
99 1140 19/11/2025 11:17:48 1336001733612358 XLON
171 1138 19/11/2025 11:23:53 1336001733612912 XLON
16 1138 19/11/2025 11:24:32 1336001733612996 XLON
92 1138 19/11/2025 11:26:26 1336001733613170 XLON
660 1136 19/11/2025 11:36:34 1336001733613958 XLON
281 1136 19/11/2025 11:51:53 1336001733615070 XLON
291 1134 19/11/2025 11:55:25 1336001733615446 XLON
77 1136 19/11/2025 12:20:26 1336001733617382 XLON
217 1134 19/11/2025 12:21:00 1336001733617419 XLON
118 1134 19/11/2025 12:26:23 1336001733617790 XLON
7 1134 19/11/2025 12:26:23 1336001733617791 XLON
79 1132 19/11/2025 12:38:44 1336001733618926 XLON
118 1132 19/11/2025 12:38:44 1336001733618928 XLON
51 1132 19/11/2025 13:04:18 1336001733621158 XLON
335 1132 19/11/2025 13:04:18 1336001733621159 XLON
700 1138 19/11/2025 13:40:12 1336001733624295 XLON
77 1138 19/11/2025 13:46:45 1336001733625012 XLON
582 1136 19/11/2025 13:52:18 1336001733625501 XLON
183 1134 19/11/2025 13:52:26 1336001733625524 XLON
479 1136 19/11/2025 14:02:46 1336001733626322 XLON
351 1136 19/11/2025 14:22:30 1336001733628038 XLON
158 1138 19/11/2025 14:29:58 1336001733628888 XLON
544 1140 19/11/2025 14:43:41 1336001733632852 XLON
15 1144 19/11/2025 15:04:36 1336001733637244 XLON
341 1144 19/11/2025 15:04:36 1336001733637245 XLON
170 1144 19/11/2025 15:15:29 1336001733639656 XLON
164 1142 19/11/2025 15:19:45 1336001733640513 XLON
290 1140 19/11/2025 15:27:18 1336001733641918 XLON
229 1140 19/11/2025 15:40:50 1336001733644683 XLON
194 1140 19/11/2025 15:40:50 1336001733644684 XLON
194 1140 19/11/2025 15:40:50 1336001733644686 XLON
654 1140 19/11/2025 15:40:50 1336001733644687 XLON
194 1140 19/11/2025 15:40:50 1336001733644688 XLON
654 1140 19/11/2025 15:40:50 1336001733644689 XLON
194 1140 19/11/2025 15:40:50 1336001733644690 XLON
194 1140 19/11/2025 15:40:50 1336001733644691 XLON
371 1140 19/11/2025 15:40:50 1336001733644692 XLON
132 1140 19/11/2025 15:40:50 1336001733644693 XLON
76 1138 19/11/2025 15:56:30 1336001733647817 XLON
194 1138 19/11/2025 16:05:00 1336001733649721 XLON
90 1138 19/11/2025 16:05:00 1336001733649723 XLON
98 1138 19/11/2025 16:05:01 1336001733649724 XLON
76 1138 19/11/2025 16:10:14 1336001733650741 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSGPGWCGUPAGMB
Copyright 2019 Regulatory News Service, all rights reserved